Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Faron Pharmaceuticals
Biotech
Faron's latest snapshot suggests antibody has leukemia potential
Faron has pointed to the latest snapshot of early-stage data as proof its antibody bexmarilimab is ready to enter phase 2 this year.
James Waldron
Jul 19, 2023 8:45am
The Clever-1? Faron hails melanoma data despite lack of response
Apr 22, 2022 5:25am
Faron fingers low bioactivity as possible cause of phase 3 flop
May 11, 2018 9:07am
Faron flummoxed as Traumakine fails in ARDS
May 8, 2018 10:29am
EuroBiotech: More Articles of Note
Mar 2, 2017 9:47am
